464 related articles for article (PubMed ID: 29156019)
1. The aspartate transaminase/alanine transaminase (DeRitis) ratio predicts mid-term mortality and renal and respiratory dysfunction after left ventricular assist device implantation.
Pilarczyk K; Carstens H; Heckmann J; Canbay A; Koch A; Pizanis N; Jakob H; Kamler M
Eur J Cardiothorac Surg; 2017 Oct; 52(4):781-788. PubMed ID: 29156019
[TBL] [Abstract][Full Text] [Related]
2. Early Right Ventricular Assist Device Use in Patients Undergoing Continuous-Flow Left Ventricular Assist Device Implantation: Incidence and Risk Factors From the Interagency Registry for Mechanically Assisted Circulatory Support.
Kiernan MS; Grandin EW; Brinkley M; Kapur NK; Pham DT; Ruthazer R; Rame JE; Atluri P; Birati EY; Oliveira GH; Pagani FD; Kirklin JK; Naftel D; Kormos RL; Teuteberg JJ; DeNofrio D
Circ Heart Fail; 2017 Oct; 10(10):. PubMed ID: 29021348
[TBL] [Abstract][Full Text] [Related]
3. Predictive value of the model for end-stage liver disease score in patients undergoing left ventricular assist device implantation.
Deo SV; Daly RC; Altarabsheh SE; Hasin T; Zhao Y; Shah IK; Stulak JM; Boilson BA; Schirger JA; Joyce LD; Park SJ
ASAIO J; 2013; 59(1):57-62. PubMed ID: 23263341
[TBL] [Abstract][Full Text] [Related]
4. Model for end-stage liver disease score predicts adverse events related to ventricular assist device therapy.
Bonde P; Ku NC; Genovese EA; Bermudez CA; Bhama JK; Ciarleglio MM; Cong X; Teuteberg JJ; Kormos RL
Ann Thorac Surg; 2012 May; 93(5):1541-7; discussion 1547-8. PubMed ID: 22480391
[TBL] [Abstract][Full Text] [Related]
5. Left ventricular assist device implantation may be feasible in appropriately selected patients with severe renal insufficiency.
Pasrija C; Tran D; George P; Sorensen E; Kaczorowski DJ; Ton VK; Kon ZN;
J Thorac Cardiovasc Surg; 2020 Apr; 159(4):1307-1319.e2. PubMed ID: 31128896
[TBL] [Abstract][Full Text] [Related]
6. Postoperative right ventricular failure after left ventricular assist device placement is predicted by preoperative echocardiographic structural, hemodynamic, and functional parameters.
Raina A; Seetha Rammohan HR; Gertz ZM; Rame JE; Woo YJ; Kirkpatrick JN
J Card Fail; 2013 Jan; 19(1):16-24. PubMed ID: 23273590
[TBL] [Abstract][Full Text] [Related]
7. Echocardiographic variables after left ventricular assist device implantation associated with adverse outcome.
Topilsky Y; Hasin T; Oh JK; Borgeson DD; Boilson BA; Schirger JA; Clavell AL; Frantz RP; Tsutsui R; Liu M; Maltais S; Kushwaha SS; Pereira NL; Park SJ
Circ Cardiovasc Imaging; 2011 Nov; 4(6):648-61. PubMed ID: 21940507
[TBL] [Abstract][Full Text] [Related]
8. Identifying Temporal Relationships Between In-Hospital Adverse Events After Implantation of Durable Left Ventricular Assist Devices.
Kilic A; Seese L; Pagani F; Kormos R
J Am Heart Assoc; 2020 Apr; 9(8):e015449. PubMed ID: 32285751
[TBL] [Abstract][Full Text] [Related]
9. Clinical Implications of Respiratory Failure in Patients Receiving Durable Left Ventricular Assist Devices for End-Stage Heart Failure.
Miller PE; Caraballo C; Ravindra NG; Mezzacappa C; McCullough M; Gruen J; Levin A; Reinhardt S; Ali A; Desai NR; Ahmad T
Circ Heart Fail; 2019 Nov; 12(11):e006369. PubMed ID: 31707800
[TBL] [Abstract][Full Text] [Related]
10. Impact of Postoperative Liver Dysfunction on Survival After Left Ventricular Assist Device Implantation.
Majumder K; Spratt JR; Holley CT; Roy SS; Cogswell RJ; Liao K; John R
Ann Thorac Surg; 2017 Nov; 104(5):1556-1562. PubMed ID: 28760474
[TBL] [Abstract][Full Text] [Related]
11. Pulmonary artery pulsatility index predicts right ventricular failure after left ventricular assist device implantation.
Kang G; Ha R; Banerjee D
J Heart Lung Transplant; 2016 Jan; 35(1):67-73. PubMed ID: 26212656
[TBL] [Abstract][Full Text] [Related]
12. Prediction of acute kidney injury after left ventricular assist device implantation: Evaluation of clinical risk scores.
Pilarczyk K; Carstens H; Papathanasiou M; Luedike P; Koch A; Jakob H; Kamler M; Pizanis N
Artif Organs; 2020 Feb; 44(2):162-173. PubMed ID: 31361341
[TBL] [Abstract][Full Text] [Related]
13. Continuous-flow left ventricular assist device therapy in patients with preoperative hepatic failure: are we pushing the limits too far?
Weymann A; Patil NP; Sabashnikov A; Mohite PN; Garcia Saez D; Bireta C; Wahlers T; Karck M; Kallenbach K; Ruhparwar A; Fatullayev J; Amrani M; De Robertis F; Bahrami T; Popov AF; Simon AR
Artif Organs; 2015 Apr; 39(4):336-42. PubMed ID: 25345547
[TBL] [Abstract][Full Text] [Related]
14. Predictor of early mortality for severe heart failure patients with left ventricular assist device implantation: significance of INTERMACS level and renal function.
Yoshioka D; Sakaguchi T; Saito S; Miyagawa S; Nishi H; Yoshikawa Y; Fukushima S; Saito T; Daimon T; Ueno T; Kuratani T; Sawa Y
Circ J; 2012; 76(7):1631-8. PubMed ID: 22484979
[TBL] [Abstract][Full Text] [Related]
15. De Ritis Ratio as a Significant Prognostic Factor in Patients with Sepsis: A Retrospective Analysis.
Zhao PY; Yao RQ; Ren C; Li SY; Li YX; Zhu SY; Yao YM; Du XH
J Surg Res; 2021 Aug; 264():375-385. PubMed ID: 33848836
[TBL] [Abstract][Full Text] [Related]
16. Left ventricular assist device outcomes based on flow configuration and pre-operative left ventricular dimension: An Interagency Registry for Mechanically Assisted Circulatory Support Analysis.
Shah P; Birk S; Maltais S; Stulak J; Elmi A; Pagani FD; Cowger JA
J Heart Lung Transplant; 2017 Jun; 36(6):640-649. PubMed ID: 28087105
[TBL] [Abstract][Full Text] [Related]
17. Changes in renal function after implantation of continuous-flow left ventricular assist devices.
Hasin T; Topilsky Y; Schirger JA; Li Z; Zhao Y; Boilson BA; Clavell AL; Rodeheffer RJ; Frantz RP; Edwards BS; Pereira NL; Joyce L; Daly R; Park SJ; Kushwaha SS
J Am Coll Cardiol; 2012 Jan; 59(1):26-36. PubMed ID: 22192665
[TBL] [Abstract][Full Text] [Related]
18. Accuracy of Postoperative Risk Scores for Survival Prediction in Interagency Registry for Mechanically Assisted Circulatory Support Profile 1 Continuous-Flow Left Ventricular Assist Device Recipients.
Critsinelis AC; Lamba HK; Nguyen MT; Conroy JR; Cheema FH; Civitello AB; Delgado RM; Nair AP; Oberton SB; Rosengart TK; Frazier OH; Morgan JA; Chatterjee S
ASAIO J; 2020 May; 66(5):539-546. PubMed ID: 31335367
[TBL] [Abstract][Full Text] [Related]
19. Outcomes after implantation of partial-support left ventricular assist devices in inotropic-dependent patients: Do we still need full-support assist devices?
Sabashnikov A; Popov AF; Bowles CT; Mohite PN; Weymann A; Hards R; Hedger M; Wittwer T; Wippermann J; Wahlers T; Schoendube FA; Simon AR
J Thorac Cardiovasc Surg; 2014 Sep; 148(3):1115-21; discussion 1021-2. PubMed ID: 25129605
[TBL] [Abstract][Full Text] [Related]
20. Model of End-Stage Liver Disease-eXcluding International Normalized Ratio (MELD-XI) Scoring System to Predict Outcomes in Patients Who Undergo Left Ventricular Assist Device Implantation.
Critsinelis A; Kurihara C; Volkovicher N; Kawabori M; Sugiura T; Manon M; Wang S; Civitello AB; Morgan JA
Ann Thorac Surg; 2018 Aug; 106(2):513-519. PubMed ID: 29626453
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
